Comparatively, the National Comprehensive Cancer Network (NCCN) guidelines only recommended anti-PD-1 antibody plus chemotherapy as the first-line treatment for advanced gastric cancer patients with PD-L1 CPS ≥ 5. The gene discussed is CD274; the disease is gastric cancer.